Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US
Public ClinicalTrials.gov record NCT00847483. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Comparison of Latanoprost (Xalatan) With Travoprost (Travatan) and Bimatoprost (Lumigan) in Patients With Elevated Intraocular Pressure. A Twelve-week, Masked Evaluator, Phase IV, Multicenter Study in the United States. (Xalatan vs Travatan vs Lumigan).
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Compare the IOP lowering properties of latanoprost, travoprost and bimatoprost
Study identification
- NCT ID
- NCT00847483
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 375 participants
Conditions and interventions
Conditions
Interventions
- latanoprost 0.005% ophthalmic solution Drug
- Travoprost 004% sterile ophthalmic solution Drug
- Bimatoprost .03% sterile ophthalmic solution Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2002 (Type not available)
- Primary completion
- Aug 2002 (Actual)
- Completion
- Aug 2002 (Actual)
- Last update posted
- Feb 2, 2021
2002
United States locations
- U.S. sites
- 40
- U.S. states
- 22
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Bellflower | California | 90706 | — |
| Pfizer Investigational Site | Inglewood | California | 90301 | — |
| Pfizer Investigational Site | San Diego | California | 92103 | — |
| Pfizer Investigational Site | San Diego | California | 92116 | — |
| Pfizer Investigational Site | San Francisco | California | 94115 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32610 | — |
| Pfizer Investigational Site | Lakeland | Florida | 33805 | — |
| Pfizer Investigational Site | Ormond Beach | Florida | 32174 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30339 | — |
| Pfizer Investigational Site | Bloomingdale | Illinois | 60108 | — |
| Pfizer Investigational Site | Evansville | Indiana | 47710 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40207 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40217 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 771104 | — |
| Pfizer Investigational Site | Bangor | Maine | 04401 | — |
| Pfizer Investigational Site | Kansas City | Missouri | 64111 | — |
| Pfizer Investigational Site | Kansas City | Missouri | 64114 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68198-5540 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89104 | — |
| Pfizer Investigational Site | Bloomfield | New Jersey | 07003 | — |
| Pfizer Investigational Site | Willingboro | New Jersey | 08046 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28210 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Pfizer Investigational Site | Streetsboro | Ohio | 44241 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73104 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74104 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15224 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29412 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29414 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29425 | — |
| Pfizer Investigational Site | Maryville | Tennessee | 37803 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38119 | — |
| Pfizer Investigational Site | Dallas | Texas | 75231 | — |
| Pfizer Investigational Site | El Paso | Texas | 79902 | — |
| Pfizer Investigational Site | Houston | Texas | 77025 | — |
| Pfizer Investigational Site | Layton | Utah | 84041 | — |
| Pfizer Investigational Site | Norfolk | Virginia | 23505 | — |
| Pfizer Investigational Site | Norfolk | Virginia | 23507 | — |
| Pfizer Investigational Site | Virginia Beach | Virginia | 23456 | — |
| Pfizer Investigational Site | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00847483, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 2, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00847483 live on ClinicalTrials.gov.